Oscar Emmanuel Garcia Moreno
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Oscar Emmanuel Garcia Moreno has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Gustavo Adrián Pineda Yáñez
Universidad de Ciencias Médicas de La Habana
2 shared publications - Jenner Moisés Cardona Páiz
Universidad San Carlos de Guatemala
2 shared publications - Luis Felipe Espinal Pérez2 shared publications
- Alberto Escamilla Huerta
Benemérita Universidad Autónoma de Puebla
1 shared publication - Alvaro Enrique Marroquin Murcia
Clínica Infantil Colsubsido
1 shared publication - Ana Camila Subia Sandoval
Investigadora independiente
1 shared publication
Latest Publications
- Open Access
- 30 June 2026
- Published by Quality Consulting Instituto de Educación Capacitación y Certificación de México in IECCMEXICO
- Vol. 5 (2)
Beyond Skin Loss: Immune Dysregulation, Infectious Complications, and Early Reconstructive Strategies in Extensive Burn Injuries
Extensive burn injuries represent a major challenge in contemporary medicine because of their complex interactions with systemic inflammation, immune dysfunction, infectious complications, and reconstructive requirements. Severe thermal injury disrupts skin barrier integrity and initiates profound immunological alterations involving innate and adaptive immune responses, creating conditions that may increase susceptibility to wound infection and systemic deterioration. This narrative review examines the immunopathological mechanisms associated with extensive burns, the microbiological characteristics of burn wound infections, and the clinical relevance of early surgical excision and reconstructive coverage. Scientific literature addressing burn pathophysiology, microbial colonization, invasive infection, antimicrobial resistance, skin grafting, and dermal substitutes was critically examined, incorporating international evidence and contributions from Latin America. The findings demonstrate that postburn immune dysfunction involves the coexistence of inflammatory activation and impaired antimicrobial defense, complicating the differentiation between sterile inflammation and infectious deterioration. Microorganisms such as Pseudomonas aeruginosa, Staphylococcus aureus, Acinetobacter species, and Enterobacterales remain clinically relevant, although their distribution varies according to institutional and geographical characteristics. Early excision of devitalized tissue and appropriate reconstructive coverage are fundamental components of burn management, particularly in patients with extensive tissue loss and limited donor-site availability. Nevertheless, differences in burn severity, surgical timing, and reported outcomes restrict direct comparisons between reconstructive techniques. The available evidence supports an integrated multidisciplinary approach combining immunological assessment, infection surveillance, antimicrobial stewardship, and individualized surgical management. Further multicenter investigations incorporating standardized clinical definitions, longitudinal immune monitoring, and consistent reconstructive outcomes are needed to optimize treatment strategies and improve survival, functional recovery, and long-term quality of life.
- 30 June 2026
- Published by Quality Consulting Instituto de Educación Capacitación y Certificación de México in IECCMEXICO
- Vol. 5 (2)
Open AccessBeyond Skin Loss: Immune Dysregulation, Infectious Complications, and Early Reconstructive Strategies in Extensive Burn Injuries
Extensive burn injuries represent a major challenge in contemporary medicine because of their complex interactions with systemic inflammation, immune dysfunction, infectious complications, and reconstructive requirements. Severe thermal injury disrupts skin barrier integrity and initiates profound immunological alterations involving innate and adaptive immune responses, creating conditions that may increase susceptibility to wound infection and systemic deterioration. This narrative review examines the immunopathological mechanisms associated with extensive burns, the microbiological characteristics of burn wound infections, and the clinical relevance of early surgical excision and reconstructive coverage. Scientific literature addressing burn pathophysiology, microbial colonization, invasive infection, antimicrobial resistance, skin grafting, and dermal substitutes was critically examined, incorporating international evidence and contributions from Latin America. The findings demonstrate that postburn immune dysfunction involves the coexistence of inflammatory activation and impaired antimicrobial defense, complicating the differentiation between sterile inflammation and infectious deterioration. Microorganisms such as Pseudomonas aeruginosa, Staphylococcus aureus, Acinetobacter species, and Enterobacterales remain clinically relevant, although their distribution varies according to institutional and geographical characteristics. Early excision of devitalized tissue and appropriate reconstructive coverage are fundamental components of burn management, particularly in patients with extensive tissue loss and limited donor-site availability. Nevertheless, differences in burn severity, surgical timing, and reported outcomes restrict direct comparisons between reconstructive techniques. The available evidence supports an integrated multidisciplinary approach combining immunological assessment, infection surveillance, antimicrobial stewardship, and individualized surgical management. Further multicenter investigations incorporating standardized clinical definitions, longitudinal immune monitoring, and consistent reconstructive outcomes are needed to optimize treatment strategies and improve survival, functional recovery, and long-term quality of life.
- Open Access
- 30 June 2026
- Published by Quality Consulting Instituto de Educación Capacitación y Certificación de México in IECCMEXICO
- Vol. 5 (2)
Beyond Hemostasis: Integrated Anticoagulation Reversal, Hemodynamic Optimization, and Neurosurgical Decision-Making in Intracerebral Hemorrhage
Anticoagulant-associated intracerebral hemorrhage represents a life-threatening neurological emergency characterized by rapid hematoma expansion, secondary cerebral injury, and substantial risks of mortality and long-term functional disability. Its management requires coordinated therapeutic strategies addressing anticoagulant activity, systemic hemodynamics, and intracranial complications. This narrative review critically examines current international evidence regarding pharmacological reversal, blood pressure management, and neurosurgical intervention, incorporating perspectives relevant to Latin American healthcare systems. Twenty scientific publications, including randomized controlled trials, observational investigations, and clinical guidelines, were analyzed through a comparative qualitative approach. Evidence from the INCH trial demonstrated more rapid normalization of coagulation parameters with four-factor prothrombin complex concentrate than with fresh frozen plasma. ANNEXA-I reported greater hemostatic efficacy with andexanet alfa compared with usual care, although thrombotic complications were more frequent and functional benefits were not established. Findings from INTERACT2 and ATACH-II highlighted differences in clinical outcomes associated with intensive blood pressure reduction, whereas INTERACT3 demonstrated improved functional outcomes through coordinated management of physiological abnormalities. Neurosurgical evidence from MISTIE III and ENRICH revealed that the effectiveness of minimally invasive hematoma evacuation depends on procedural technique, anatomical characteristics, treatment timing, and patient selection. Across the reviewed studies, improvements in hemostatic or radiological parameters did not consistently translate into reduced mortality or sustained neurological recovery. The findings support an individualized, multidisciplinary approach integrating prompt anticoagulant reversal, controlled hemodynamic stabilization, continuous neurological assessment, and selective neurosurgical treatment. Further investigations are needed to establish optimal therapeutic sequencing, anticoagulant-specific surgical criteria, and implementation strategies adapted to resource-variable healthcare environments.
- 30 June 2026
- Published by Quality Consulting Instituto de Educación Capacitación y Certificación de México in IECCMEXICO
- Vol. 5 (2)
Open AccessBeyond Hemostasis: Integrated Anticoagulation Reversal, Hemodynamic Optimization, and Neurosurgical Decision-Making in Intracerebral Hemorrhage
Anticoagulant-associated intracerebral hemorrhage represents a life-threatening neurological emergency characterized by rapid hematoma expansion, secondary cerebral injury, and substantial risks of mortality and long-term functional disability. Its management requires coordinated therapeutic strategies addressing anticoagulant activity, systemic hemodynamics, and intracranial complications. This narrative review critically examines current international evidence regarding pharmacological reversal, blood pressure management, and neurosurgical intervention, incorporating perspectives relevant to Latin American healthcare systems. Twenty scientific publications, including randomized controlled trials, observational investigations, and clinical guidelines, were analyzed through a comparative qualitative approach. Evidence from the INCH trial demonstrated more rapid normalization of coagulation parameters with four-factor prothrombin complex concentrate than with fresh frozen plasma. ANNEXA-I reported greater hemostatic efficacy with andexanet alfa compared with usual care, although thrombotic complications were more frequent and functional benefits were not established. Findings from INTERACT2 and ATACH-II highlighted differences in clinical outcomes associated with intensive blood pressure reduction, whereas INTERACT3 demonstrated improved functional outcomes through coordinated management of physiological abnormalities. Neurosurgical evidence from MISTIE III and ENRICH revealed that the effectiveness of minimally invasive hematoma evacuation depends on procedural technique, anatomical characteristics, treatment timing, and patient selection. Across the reviewed studies, improvements in hemostatic or radiological parameters did not consistently translate into reduced mortality or sustained neurological recovery. The findings support an individualized, multidisciplinary approach integrating prompt anticoagulant reversal, controlled hemodynamic stabilization, continuous neurological assessment, and selective neurosurgical treatment. Further investigations are needed to establish optimal therapeutic sequencing, anticoagulant-specific surgical criteria, and implementation strategies adapted to resource-variable healthcare environments.
- Open Access
- 30 June 2026
- Published by Quality Consulting Instituto de Educación Capacitación y Certificación de México in IECCMEXICO
- Vol. 5 (2)
Beyond Cutaneous Injury: Immunopathogenesis, Early Recognition, and Therapeutic Challenges in DRESS and Stevens–Johnson Syndrome/Toxic Epidermal Necrolysis
Severe cutaneous adverse drug reactions represent a major clinical challenge due to their complex immunological mechanisms, heterogeneous manifestations, and potential to cause life-threatening systemic complications. This narrative review examines the immunopathogenesis, early recognition, diagnostic assessment, and therapeutic management of drug reaction with eosinophilia and systemic symptoms (DRESS) and Stevens–Johnson syndrome/toxic epidermal necrolysis (SJS/TEN). Twenty scientific publications, including clinical investigations, systematic reviews, and international consensus recommendations, were analyzed through a qualitative synthesis incorporating contributions from Latin America. The findings revealed distinct patterns of immune-mediated injury, characterized by systemic inflammation, T-cell activation, and potential herpesvirus reactivation in DRESS, compared with cytotoxic keratinocyte destruction mediated by granulysin and other inflammatory pathways in SJS/TEN. Clinical evidence emphasized the relevance of early drug withdrawal, multidisciplinary assessment, and standardized instruments, including RegiSCAR, ALDEN, and SCORTEN. Therapeutic investigations identified potentially favorable outcomes associated with selected immunomodulatory interventions, including systemic corticosteroids, cyclosporine, and tumor necrosis factor-alpha inhibitors; however, methodological heterogeneity and limited randomized evidence restrict definitive conclusions regarding comparative effectiveness. Latin American contributions highlighted the importance of regional clinical guidelines and improved access to specialized care. Overall, integrating immunological knowledge with structured clinical assessment and evidence-based management may contribute to earlier recognition and more individualized care. Further multicenter investigations are required to clarify therapeutic effectiveness, identify reliable biomarkers, and improve long-term outcomes.
- 30 June 2026
- Published by Quality Consulting Instituto de Educación Capacitación y Certificación de México in IECCMEXICO
- Vol. 5 (2)
Open AccessBeyond Cutaneous Injury: Immunopathogenesis, Early Recognition, and Therapeutic Challenges in DRESS and Stevens–Johnson Syndrome/Toxic Epidermal Necrolysis
Severe cutaneous adverse drug reactions represent a major clinical challenge due to their complex immunological mechanisms, heterogeneous manifestations, and potential to cause life-threatening systemic complications. This narrative review examines the immunopathogenesis, early recognition, diagnostic assessment, and therapeutic management of drug reaction with eosinophilia and systemic symptoms (DRESS) and Stevens–Johnson syndrome/toxic epidermal necrolysis (SJS/TEN). Twenty scientific publications, including clinical investigations, systematic reviews, and international consensus recommendations, were analyzed through a qualitative synthesis incorporating contributions from Latin America. The findings revealed distinct patterns of immune-mediated injury, characterized by systemic inflammation, T-cell activation, and potential herpesvirus reactivation in DRESS, compared with cytotoxic keratinocyte destruction mediated by granulysin and other inflammatory pathways in SJS/TEN. Clinical evidence emphasized the relevance of early drug withdrawal, multidisciplinary assessment, and standardized instruments, including RegiSCAR, ALDEN, and SCORTEN. Therapeutic investigations identified potentially favorable outcomes associated with selected immunomodulatory interventions, including systemic corticosteroids, cyclosporine, and tumor necrosis factor-alpha inhibitors; however, methodological heterogeneity and limited randomized evidence restrict definitive conclusions regarding comparative effectiveness. Latin American contributions highlighted the importance of regional clinical guidelines and improved access to specialized care. Overall, integrating immunological knowledge with structured clinical assessment and evidence-based management may contribute to earlier recognition and more individualized care. Further multicenter investigations are required to clarify therapeutic effectiveness, identify reliable biomarkers, and improve long-term outcomes.
- Open Access
- 30 June 2026
- Published by Quality Consulting Instituto de Educación Capacitación y Certificación de México in IECCMEXICO
- Vol. 5 (2)
Patient-Centered Facial and Orofacial Reconstruction After Cutaneous Cancer Resection: Integrating Function, Aesthetics, and Quality of Life
Facial and orofacial reconstruction following cutaneous oncologic resection represents a complex clinical challenge in which tumor control must be integrated with preservation of function, restoration of facial appearance, and maintenance of quality of life. This study analyzed contemporary reconstructive strategies used after facial skin cancer excision, with emphasis on the relationship between defect characteristics, anatomical location, surgical technique, functional recovery, aesthetic integration, postoperative complications, and patient-reported outcomes. A structured review was conducted under the Scientific Method framework, incorporating clinical guidelines, systematic reviews, observational studies, reconstructive case series, and investigations focused on patient-reported outcomes. The findings showed that reconstructive success depends primarily on individualized surgical planning rather than on the superiority of a single technique. Primary closure, skin grafts, local flaps, regional or staged flaps, and microvascular free-tissue transfer provide different advantages according to defect size, depth, tissue involvement, and functional requirements. Nasal reconstruction requires preservation of airway patency and structural support; periocular reconstruction prioritizes ocular protection and eyelid closure; and lip and perioral reconstruction requires maintenance of oral competence, speech, and feeding. The evidence also demonstrated that flap survival and wound healing alone are insufficient to define successful reconstruction. Aesthetic integration, complication burden, patient satisfaction, psychological well-being, and social reintegration must also be considered. Patient-reported outcome measures, including the FACE-Q Skin Cancer Module, strengthen the assessment of reconstructive effectiveness. Overall, the evidence supports a multidimensional and patient-centered approach in which oncologic safety, function, aesthetics, and quality of life are balanced to achieve comprehensive recovery after facial and orofacial cancer surgery.
- 30 June 2026
- Published by Quality Consulting Instituto de Educación Capacitación y Certificación de México in IECCMEXICO
- Vol. 5 (2)
Open AccessPatient-Centered Facial and Orofacial Reconstruction After Cutaneous Cancer Resection: Integrating Function, Aesthetics, and Quality of Life
Facial and orofacial reconstruction following cutaneous oncologic resection represents a complex clinical challenge in which tumor control must be integrated with preservation of function, restoration of facial appearance, and maintenance of quality of life. This study analyzed contemporary reconstructive strategies used after facial skin cancer excision, with emphasis on the relationship between defect characteristics, anatomical location, surgical technique, functional recovery, aesthetic integration, postoperative complications, and patient-reported outcomes. A structured review was conducted under the Scientific Method framework, incorporating clinical guidelines, systematic reviews, observational studies, reconstructive case series, and investigations focused on patient-reported outcomes. The findings showed that reconstructive success depends primarily on individualized surgical planning rather than on the superiority of a single technique. Primary closure, skin grafts, local flaps, regional or staged flaps, and microvascular free-tissue transfer provide different advantages according to defect size, depth, tissue involvement, and functional requirements. Nasal reconstruction requires preservation of airway patency and structural support; periocular reconstruction prioritizes ocular protection and eyelid closure; and lip and perioral reconstruction requires maintenance of oral competence, speech, and feeding. The evidence also demonstrated that flap survival and wound healing alone are insufficient to define successful reconstruction. Aesthetic integration, complication burden, patient satisfaction, psychological well-being, and social reintegration must also be considered. Patient-reported outcome measures, including the FACE-Q Skin Cancer Module, strengthen the assessment of reconstructive effectiveness. Overall, the evidence supports a multidimensional and patient-centered approach in which oncologic safety, function, aesthetics, and quality of life are balanced to achieve comprehensive recovery after facial and orofacial cancer surgery.